Review of the Institute of Genetics (IG) – Management Response Action Plan (MRAP)
Evaluation: Institute of Genetics (IG)
Evaluation completed: 2017/18
Evaluation lead: CIHR
| Recommendation | Response (Agree/Disagree) |
Management Action Plan | Responsibility | Timeline |
|---|---|---|---|---|
| 1. The Panel recommends that the Institute of Genetics (IG) continue with the current mandate. | Agree | Maintain IG mandate | Governing Council | 2018/19 (Complete) |
| 2a. The Panel recommends that the next Scientific Director direct more attention to computational biology and computational medicine as these areas will revolutionize medicine. | Agree | Computational biology and computational medicine to be incorporated into new IG strategic plan as appropriate | Scientific Director, Institute of Genetics in collaboration with the Vice-President, Research Programs | 2019/20 |
| 2b. The Panel recommends that CIHR commit an additional $4 M per year to support new investments in areas of strategic priority given the breadth of IG's mandate and available Institute resources. | Disagree with specific recommendation but will continue to monitor as part of broader evaluation of institute support. | Resourcing and support to CIHR’s 13 institutes is assessed horizontally as part of CIHR’s normal practice, rather than on an Institute specific basis. The outcomes of this assessment will inform the future state of resourcing and funding of all institutes | Executive Management Committee to monitor; Governing Council to approve | Ongoing |
| 3. The Panel recommends that the next Scientific Director, in consultation with the Institute Advisory Board, develop a strategy to assess the ongoing research priorities in order to ensure that emerging areas under the IG mandate can be prioritized. | Agree | Renewed IG strategic plan to be developed in consultation with the IG research community and Institute advisory board, and will include consideration for computational biology and computational medicine. | Scientific Director, Institute of Genetics in collaboration with the Vice-President, Research Programs | 2019/20 |
| 4a. The Panel recommends that the next Scientific Director develops an effective communication strategy about the mandate and funding opportunities sponsored by IG with a particular emphasis on early career investigators. | Agree | Develop communication strategy and implement workshops to highlight IG funding opportunities and methods of support (including support for early career investigators) | Scientific Director, Institute of Genetics in collaboration with the Vice-President, Research Programs Executive Vice-President, Governance and External Relations | 2018/19 |
| 4b. The Panel recommends that the IG explores ways to increase involvement of early career investigators in their funding opportunities. As one example, the IG could require the presence of early career investigators in team grants. | Agree | Identify options for increased support for early career investigators in funding opportunities as part of strategic planning process | Scientific Director, Institute of Genetics | 2018/19 |
- Date modified: